To The Moon

$Palantir Technologies Inc.(PLTR)$ Don't pass Go. Don't collect $200. That old Monopoly warning is exactly what the bears and doubters are telling themselves about PLTR right now. They are sitting on the sidelines calling it overvalued while the company keeps delivering explosive growth, expanding margins, and raising guidance. Palantir's AIP, Ontology, and commercial traction are still in extremely early innings. Does anyone have an idea where this AI buildout will be in 5 years? Probably not, but we do know PLTR will be at the center of it all. That said, the current price is not the finish line; it is the starting gate. The bears who refuse to pass Go will watch the bulls and everyone else invested in PLTR collect the upside later. The dow

$Palantir Technologies Inc.(PLTR)$  Bears are getting hyped up over it only being up around 7.3%, acting like they won something.

$Palantir Technologies Inc.(PLTR)$ Something missing here? Karp and the team just posted their best earnings ever, with guidance pointing to 100% YoY growth over the next 18 months. Besides, PLTR dips always seem to get bought up. Yeah, always. I keep buying those dips.

$Palantir Technologies Inc.(PLTR)$  Palantir got a nice mention on CNBC today as one of the drivers behind software stock momentum, along with how shorts have been getting squeezed since its blowout earnings.

$Palantir Technologies Inc.(PLTR)$  Where did all the bears and shorts go?

$Ondas Holdings Inc.(ONDS)$ We're back. Strong hands have been accumulating a lot over the past few months. The $Palantir Technologies Inc.(PLTR)$  and $Lockheed Martin(LMT)$  partnerships show our worth. Last earnings call forward guidance should carry this higher through the rest of the year. The weekly chart is speaking the language.

$Palantir Technologies Inc.(PLTR)$ Shorts are feeling the heat again today. There's still time for them to exit before the rally expected in September. Sounds like Burry's crystal ball needs some repairs.

$Palantir Technologies Inc.(PLTR)$ Listless in either direction on pathetic volume, roughly half of normal at the close. Still managed to outperform the broader market by 1.0%. I'll take it.

$AbCellera Biologics(ABCL)$ $AbCellera Biologics(ABCL)$ ABCL is quietly becoming the Palantir of antibodies. Palantir built the data engine. ABCL is building the AI engine for drug discovery. They're not just chasing one drug at a time. They're creating the operating system that helps pharma companies find treatments faster. Their tech basically maps the immune system, sifting through millions of cells to hunt down the right antibody. Both companies are good at turning messy, massive datasets into something useful when everyone else just sees noise. ABCL is trying to change how medicine gets made.

Visionary leadership is something people tend to underestimate. It can shift the direction of entire countries, so anything less just feels like business as usual. I've been holding $Palantir Technologies Inc.(PLTR)$  since the DPO, and I share the vision.